UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of July 2024
Commission File Number: 001-41641
SHL TELEMEDICINE LTD.
(Translation of registrant’s name into English)
90 Yigal Alon Street
Tel Aviv 67891, Israel
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
EXPLANATORY NOTE
On July 29, 2024, SHL Telemedicine Ltd. (the “Company”) issued a press release, a copy of which is furnished herewith as Exhibit 99.1. In the press release, the Company
announced that it has appointed David Arnon to serve as the Company’s new Chief Executive Officer, effective August 6, 2024. As previously disclosed in the Company’s Form 6-K filed with the Securities and Exchange Commission on March 14, 2024, Erez
Nachtomy, the Company’s current CEO, announced his resignation, which will be effective upon Mr. Arnon assuming the position of CEO.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.
|
SHL Telemedicine Ltd.
|
|
|
|
|
|
|
By:
|
/s/ Amir Hai |
|
|
|
Amir Hai |
|
|
|
Chief Financial Officer |
|
|
July 29, 2024
|
|
|
|
Press release
Ad hoc announcement pursuant to Art. 53 LR
SHL Telemedicine to appoint David Arnon as CEO of SHL Telemedicine
David Arnon held senior leadership and CEO roles within the healthcare insurance industry at Harel Insurance and Clal Insurance, two of the largest insurance groups in Israel.
Tel
Aviv / Zurich / New York, July 29, 2024 - SHL Telemedicine Ltd. (NASDAQ: SHLT, SIX: SHLTN;) ("SHL" or the "Company"), a leading provider and developer of advanced
personal telemedicine solutions, has announced today that it has appointed Mr. David Arnon as CEO of the Company. He will join SHL Telemedicine and assume the role
on August 6, 2024, succeeding Erez Nachtomy, who, as previously announced, will step down as CEO.
Mr. Arnon has over 17
years of commercial and executive level management experience within the healthcare insurance industry in Israel. He has extensive experience in establishing and
leading sales, marketing and operations teams, successfully developing and commercializing products, working closely with leading stakeholders in the healthcare industry in Israel including sick funds, public and private hospitals
and medical providers.
Yariv Alroy, Chairman of SHL said: “The Board welcomes David as our new CEO and looks forward to
working closely with him. He is a proven leader of large, high growth organizations, has extensive operational and planning expertise, and an excellent understanding of customer management in general and in the healthcare field in particular. We
would also like to thank Erez Nachtomy for successfully leading SHL during the last four years through a challenging period. We are sincerely grateful for his service and leadership.”
David Arnon commented: “I am honored to join SHL Telemedicine, a pioneer in telemedicine solutions.
This is an exciting time for the Company as we continue to innovate and expand our offerings in the rapidly evolving healthcare landscape. I look forward to working with the talented team at SHL to drive our vision forward, enhance patient care
through cutting-edge technology, and strengthen our market presence globally. Together, we will build on the Company’s leaderships and aim for new heights in delivering exceptional telemedicine
services.”
David Arnon joins SHL from Doral Group (TASE:DORL), a prominent company in renewable energy, where
he served as CEO of DORAL MEA. From 2018 to 2022, he was the Deputy CEO and Head of the Health Division and Customer Strategy at Clal Insurance and Finance, a subsidiary of Clal Insurance Enterprises Holdings (TASE:CLIS), one of Israel's leading
insurance groups. Between 2007 and 2018, David held various executive roles at Harel Insurance Investments and Financial Services (TASE:HARL), Israel's largest insurance group. His final role at Harel was as CEO of Standard Insurances, a leading
insurance agency within the group, overseeing more than 500 employees. David holds a BA from the University of Maryland and an MBA from Cornell University.
The Company will be publishing an invitation to a Special General Meeting of the Shareholders for
approval of Mr. Arnon’s employment agreement and terms of compensation.
About SHL Telemedicine
SHL Telemedicine is engaged in developing and marketing personal telemedicine systems and the
provision of medical call center services, with a focus on cardiovascular and related diseases, to end users and to the healthcare community. SHL Telemedicine offers its services and personal telemedicine devices to subscribers utilizing telephonic
and Internet communication technology. SHL is listed on the SIX Swiss Exchange (SHLTN, ISIN: IL0010855885, Security No.: 1128957) and on the Nasdaq Stock Exchange (SHLT, ISIN: US78423T2006, CUSIP: 78423T200).
For more information, please visit our
website at www.shl-telemedicine.com.
Contacts
Fabienne Farner, IRF, Phone : +41 43 244 81 42, farner@irf-reputation.ch
Forward-Looking Statements
Some of the information contained in this press release contains forward-looking
statements. Readers are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those in the forward- looking statements as a
result of various factors. SHL Telemedicine undertakes no obligation to
publicly update or
revise any forward-looking statements.
